Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
Majed Ghattas, Garima Dwivedi, Marc Lavertu, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1490-1490
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Immunomodulatory biomaterials against bacterial infections: Progress, challenges, and future perspectives
Shutao Zhang, Hongtao Yang, Minqi Wang, et al.
The Innovation (2023) Vol. 4, Iss. 6, pp. 100503-100503
Open Access | Times Cited: 60
Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
Xanthippi Topalidou, Alexis M. Kalergis, Georgios Papazisis
Pathogens (2023) Vol. 12, Iss. 10, pp. 1259-1259
Open Access | Times Cited: 60
Protein subunit vaccines: Promising frontiers against COVID-19
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 19
Chitosan immunomodulation: insights into mechanisms of action on immune cells and signaling pathways
Majed Ghattas, Garima Dwivedi, Anik Chevrier, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 896-909
Open Access | Times Cited: 5
Tuberculosis vaccines and therapeutic drug: challenges and future directions
Yajing An, Ruizi Ni, Zhuang Li, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 3
mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV
Laura Matarazzo, Paulo Bettencourt
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
An Overview of the Use of Nanoparticles in Vaccine Development
Daniel Lozano, Vicente Larraga, Maria Vallet‐Regí, et al.
Nanomaterials (2023) Vol. 13, Iss. 12, pp. 1828-1828
Open Access | Times Cited: 26
Facilitating the development of urgently required combination vaccines
William P. Hausdorff, Shabir A. Madhi, Gagandeep Kang, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 6, pp. e1059-e1067
Open Access | Times Cited: 12
PANDEMIC EPIDEMIOLOGY: A COMPREHENSIVE REVIEW OF COVID-19 LESSONS AND FUTURE HEALTHCARE PREPAREDNESS
Olufunke Omotayo, Muridzo Muonde, Tolulope O Olorunsogo, et al.
International Medical Science Research Journal (2024) Vol. 4, Iss. 1, pp. 89-107
Open Access | Times Cited: 10
Advances in nucleic acid-based cancer vaccines
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
Cancer vaccines: current status and future directions
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Molecular Farming for Immunization: Current Advances and Future Prospects in Plant-Produced Vaccines
Dang-Khoa Vo, Kieu The Loan Trinh
Vaccines (2025) Vol. 13, Iss. 2, pp. 191-191
Open Access | Times Cited: 1
Marginal-zone B cells as promising targets of an mRNA-loaded, lipid-nanoparticle cancer vaccine
Yuichi Suzuki, Mai Yakuwa, Mina Sato, et al.
Next Nanotechnology (2025) Vol. 8, pp. 100154-100154
Open Access | Times Cited: 1
A rapid human vaccine process development map outlining lessons learnt from ChAdOx1 nCoV-19 vaccine during the COVID-19 pandemic
Michael J. Francis
Vaccine (2025) Vol. 55, pp. 127040-127040
Closed Access | Times Cited: 1
Current progress in the development of prophylactic and therapeutic vaccines
Tingting Li, Ciying Qian, Ying Gu, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 4, pp. 679-710
Open Access | Times Cited: 32
Recent Advances of Emerging Spleen‐Targeting Nanovaccines for Immunotherapy
Xuanyi He, Jing Wang, Yuqing Tang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 23
Closed Access | Times Cited: 21
A Comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response
Saurav Kumar Jha, Mohammad Imran, Laxmi Akhileshwar Jha, et al.
Environmental Research (2023) Vol. 236, pp. 116823-116823
Closed Access | Times Cited: 20
Animal Cell Lines as Expression Platforms in Viral Vaccine Production: A Post Covid-19 Perspective
S. Furkan Demirden, Ilgin Kimiz‐Gebologlu, Suphi Ş. Öncel
ACS Omega (2024)
Open Access | Times Cited: 7
COVID-19 Variants and Vaccine Development
Ziyao Zhao, Sahra Bashiri, Zyta M. Ziora, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 757-757
Open Access | Times Cited: 6
Research progress on extraction technology and biological activity of polysaccharides from Edible Fungi: A review
Qi Guo, Shuangmin Liang, Zhichao Xiao, et al.
Food Reviews International (2022) Vol. 39, Iss. 8, pp. 4909-4940
Closed Access | Times Cited: 23
A Structural View at Vaccine Development against M. tuberculosis
Maria Romanò, Flavia Squeglia, Eliza Kramarska, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 317-317
Open Access | Times Cited: 16
Microfluidic-based technologies for diagnosis, prevention, and treatment of COVID-19: recent advances and future directions
E. Alperay Tarim, Müge Anıl-İnevi, Ilayda Ozkan, et al.
Biomedical Microdevices (2023) Vol. 25, Iss. 2
Open Access | Times Cited: 16
mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions
Ryo Okuyama
Vaccines (2023) Vol. 11, Iss. 12, pp. 1737-1737
Open Access | Times Cited: 14
Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness
Anirudha Chattopadhyay, A. Abdul Kader Jailani, Bikash Mandal
Vaccines (2023) Vol. 11, Iss. 8, pp. 1347-1347
Open Access | Times Cited: 13
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections
Léo Sauvat, Paul O. Verhoeven, Julie Gagnaire, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top